Chemical Genetics Reveals a Specific Requirement for Cdk2 Activity in the DNA Damage Response and Identifies Nbs1 as a Cdk2 Substrate in Human Cells
Lara Wohlbold(Tata Institute of Fundamental Research), Robert P. Fisher(Icahn School of Medicine at Mount Sinai), Karl A. Merrick(Memorial Sloan Kettering Cancer Center), Ramon Amat(Vall d'Hebron Institut de Recerca), Saurav De(Memorial Sloan Kettering Cancer Center), Stéphane Larochelle(Icahn School of Medicine at Mount Sinai), Kevan M. Shokat(Howard Hughes Medical Institute), Chao Zhang(China Pharmaceutical University), Jun Hyun Kim(Memorial Sloan Kettering Cancer Center), Jasmina J. Allen(Howard Hughes Medical Institute), John H.J. Petrini(Memorial Sloan Kettering Cancer Center)
Cited by 62
Related Papers
K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions
|Nature|2013|2.5k
RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF
|Nature|2010|1.8k
IRE1 Signaling Affects Cell Fate During the Unfolded Protein Response
|Science|2007|1.4k